Anxiety Disorders And Depression Treatment Market Size, Share & Trends Analysis Report By Drug (Antidepressants, Anxiolytics, Anticonvulsants, & Others), By Indication, By Distribution Channel, By Region, And Segment Forecasts, 2024

Description

Anxiety Disorders And Depression Treatment Market Growth & Trends:

The global anxiety disorders and depression treatment market is expected to reach a value of USD 15.88 billion by 2030. The market is projected to grow at a CAGR of 3.6% from 2024 to 2030. The rising incidence of depression worldwide is anticipated to drive the market growth in the coming years. Increasing adoption of devices and psychotherapies has resulted in the declining demand for antidepressants in recent years.

The rising geriatric population prone to depression and surging prevalence of anxiety disorders, including phobias and generalized anxiety disorder, are further contributing toward the growing demand for antidepressants to treat mental illnesses over the forecast period. Moreover, the introduction of technologically advanced therapies, such as medical implants used for brain stimulation and virtual reality exposure therapies using smartphone-based applications, furnish patients with innovative treatment alternatives.

Anxiety Disorders And Depression Treatment Market Report Highlights:

Presently, the antidepressant drugs segment holds the largest revenue share. However, due to the rising occurrence of adverse events associated with these therapeutics, this segment's growth is expected to wane
Patent expiration of branded medicines and the introduction of generic biosimilars, which are cost-effective, are responsible for the shrinking market of antidepressants
On the other hand, the introduction of new medicines, such as Duloxetine, Fetzima, and Brintellix, is predicted to fuel the demand for therapeutics in the coming years
Furthermore, the personalized therapies and devices segment is expected to register the fastest growth owing to its growing adoption by healthcare professionals as they exert fewer side effects as compared to drugs
North American regional segment for anxiety disorders and depression treatment reached a saturation level owing to the availability of several medicines and the high prevalence of depressive disorders in this region
The revenue captured by antidepressants is expected to decrease with generics dominating the market during the forecast period

Product Code: GVR-1-68038-731-5

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Anxiety Disorders and Depression Treatment Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Anxiety Disorders and Depression Treatment Market Variables Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Anxiety Disorders and Depression Treatment Market Variables : Drugs Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Anxiety Disorders and Depression Treatment Market Variables Market: Solution Movement Analysis, USD Million, 2023 & 2030
4.3. Antidepressants
- 4.3.1. Antidepressants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4. Anxiolytics
- 4.4.1. Anxiolytics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Anticonvulsants
- 4.5.1. Anticonvulsants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Noradrenergic Agents
- 4.6.1. Noradrenergic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Atypical Antipsychotics
- 4.7.1. Atypical Antipsychotics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Anxiety Disorders and Depression Treatment Market : Indication Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Anxiety Disorders and Depression Treatment Market: Technology Movement Analysis, USD Million, 2023 & 2030
5.3. Depression
- 5.3.1. Depression Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Anxiety
- 5.4.1. Anxiety Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Anxiety Disorders and Depression Treatment Market : Distribution Channel Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Anxiety Disorders and Depression Treatment Market: End-user Movement Analysis, USD Million, 2023 & 2030
6.3. Hospitals
- 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Retail Pharmacies
- 6.4.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Online Pharmacies
- 6.5.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Anxiety Disorders and Depression Treatment Market : Regional Estimates & Trend Analysis

7.1. Anxiety Disorders and Depression Treatment Market Share, By Region, 2023 & 2030, USD Million
7.2. North America
- 7.2.1. North America Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.2. U.S.
  - 7.2.2.1. U.S. Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.3. Canada
  - 7.2.3.1. Canada Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.4. Mexico
  - 7.2.4.1. Mexico Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
- 7.3.1. Europe Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. UK
  - 7.3.2.1. UK Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Germany
  - 7.3.3.1. Germany Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.4. France
  - 7.3.4.1. France Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
- 7.4.1. Asia Pacific Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. China
  - 7.4.2.1. China Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Japan
  - 7.4.3.1. Japan Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. India
  - 7.4.4.1. India Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.5. South Korea
  - 7.4.5.1. South Korea Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.6. Australia
  - 7.4.6.1. Australia Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
- 7.5.1. Latin America Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. Brazil
  - 7.5.2.1. Brazil Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
- 7.6.1. Middle East and Africa Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. Saudi Arabia
  - 7.6.2.1. Saudi Arabia Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. UAE
  - 7.6.3.1. UAE Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. South Africa
  - 7.6.4.1. South Africa Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
- 8.4.1. Pfizers Inc.
  - 8.4.1.1. Participant's Overview
  - 8.4.1.2. Financial Performance
  - 8.4.1.3. Product Benchmarking
  - 8.4.1.4. Recent Developments/ Strategic Initiatives
- 8.4.2. H. Lundbeck A/S
  - 8.4.2.1. Participant's Overview
  - 8.4.2.2. Financial Performance
  - 8.4.2.3. Product Benchmarking
  - 8.4.2.4. Recent Developments/ Strategic Initiatives
- 8.4.3. Glaxo SmithKline Pharmaceuticals Ltd.
  - 8.4.3.1. Participant's Overview
  - 8.4.3.2. Financial Performance
  - 8.4.3.3. Product Benchmarking
  - 8.4.3.4. Recent Developments/ Strategic Initiatives
- 8.4.4. Merck & Co., Inc.
  - 8.4.4.1. Participant's Overview
  - 8.4.4.2. Financial Performance
  - 8.4.4.3. Product Benchmarking
  - 8.4.4.4. Recent Developments/ Strategic Initiatives
- 8.4.5. Eli Lilly & Company
  - 8.4.5.1. Participant's Overview
  - 8.4.5.2. Financial Performance
  - 8.4.5.3. Product Benchmarking
  - 8.4.5.4. Recent Developments/ Strategic Initiatives
- 8.4.6. AstraZeneca
  - 8.4.6.1. Participant's Overview
  - 8.4.6.2. Financial Performance
  - 8.4.6.3. Product Benchmarking
  - 8.4.6.4. Recent Developments/ Strategic Initiatives
- 8.4.7. Bristol-Myers Squibb
  - 8.4.7.1. Participant's Overview
  - 8.4.7.2. Financial Performance
  - 8.4.7.3. Product Benchmarking
  - 8.4.7.4. Recent Developments/ Strategic Initiatives
- 8.4.8. Johnson & Johnson
  - 8.4.8.1. Participant's Overview
  - 8.4.8.2. Financial Performance
  - 8.4.8.3. Product Benchmarking
  - 8.4.8.4. Recent Developments/ Strategic Initiatives
- 8.4.9. AbbVie Inc.
  - 8.4.9.1. Participant's Overview
  - 8.4.9.2. Financial Performance
  - 8.4.9.3. Product Benchmarking
  - 8.4.9.4. Recent Developments/ Strategic Initiatives
- 8.4.10. Sanofi
  - 8.4.10.1. Participant's Overview
  - 8.4.10.2. Financial Performance
  - 8.4.10.3. Product Benchmarking
  - 8.4.10.4. Recent Developments/ Strategic Initiatives

Anxiety Disorders And Depression Treatment Market Size, Share & Trends Analysis Report By Drug (Antidepressants, Anxiolytics, Anticonvulsants, & Others), By Indication, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030